Remove Big Data Remove Engineer Remove Genomics Remove Life Science
article thumbnail

Big data – charting a new path to drug discovery and development

Drug Discovery World

Tim Lowery , President, JSR Life Sciences, asks whether artificial intelligence can do for life sciences what it has done in other sectors and whether these tools can keep up with the complexities of human biology. So, where do we go from here to realise their potential in life sciences?

article thumbnail

Bioinformatics Jobs: How to Succeed in This Competitive Space

XTalks

Bioinformatics jobs are commonly found in the fields of computer information science, pharmaceuticals, biotechnology, medical technology, computational biology, proteomics and medical informatics. The Human Genome Project could not have succeeded without the use of bioinformatics. Wondering which bioinformatics job is right for you?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How digital innovation is helping therapeutics to get to market faster

Drug Discovery World

Researchers from the University of Oslo, University of Chicago Pritzker School of Medicine, and Insilico Medicine used an AI target discovery engine to analyse transcriptomic data to identify dual targets for cancer and ageing 5.

article thumbnail

How big data analytics can make personalised care a reality

Drug Discovery World

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. He holds an MS degree in Statistics and a BS-equivalent in Bioengineering.

article thumbnail

The challenges and trends of cell & gene therapies 

Drug Discovery World

The mysteries of cancer are starting to yield to the range of advanced therapies available and cell therapies – especially engineered cell therapies – are at the leading edge of that progress.” – Carlo Russo, CEO of Genenta.? . “In Research into genomic medicines is only at its infancy. Chris Nowers, CEO, ONK Therapeutics. . “

article thumbnail

The rise of real-world evidence: unlocking the potential in EHRs

pharmaphorum

There are a good number of use cases as to why pretty much every big life science company is choosing us these days,” says Medrano. Life sciences companies are interested in understanding the behaviour of the patients and the pathologies where they are working. AI use in the pandemic.

Doctors 116
article thumbnail

Syntegra Partnering with National Institutes of Health (NIH) and the Bill and Melinda Gates Foundation to Democratize Access to the Largest Set of COVID-19 Patient Records

The Pharma Data

There has never been a time when rapid, low burden access to patient-level data, at scale, was more urgent. rows of data. There has never been a time when rapid, low burden access to patient-level data, at scale, was more urgent. rows of data. About Syntegra.